Loading...
Insights2021-01-12T11:48:07-05:00

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Precision Medicine Group Releases Its Inaugural Environmental, Social and Governance (ESG) Report

Cell & Gene Therapy, News, Thought Leadership|

Precision is proud to have published our inaugural 2023 Environmental, Social and Governance (ESG) Report, reflecting the company’s ongoing efforts to do better for our people, in our practices, and with the broader community at large. This year’s report shares key achievements, performance metrics, and steps we have taken to enhance sustainability throughout the company, including:

· Engaging internal and external stakeholders in our company’s first ESG materiality assessment to identify and prioritize our material issues

· Defining Precision’s approach to ESG in our company’s ESG Strategy Statement · Creating a three-year strategic ESG Roadmap for advancing our performance across environmental, social, and governance issues · Initiating energy efficiency projects and standards across our facilities

· Implementing implicit bias training for our Executive Leadership Team and Human Resources leaders

· Contributing volunteer hours by over 425 employees and over $250,000 in donations to more than 70 charitable foundations and causes

 

(more…)

Article: Generative AI Holds the Key to Transforming Trial Design

Thought Leadership|

Recent AI applications rely heavily on predictive AI, which harnesses historical data to make predictions and recommendations for the future. But what is really propelling the industry forward is generative AI, which uses models or algorithms to create various types of content using learned patterns based on the data on which it was trained.

SVP/Chief Architect Tobias Guennel outlines how generative AI will speed up clinical trial execution as sponsors integrate AI-enabled technologies into their day-to-day workflows.

(more…)

White Paper: Unleashing the Power of Precision Medicine: Radioligand Therapy

Cell & Gene Therapy, News, Thought Leadership|

This article was originally published on This Month in Transformative Medicine on October 17, 2023

The current standard of cancer care has saved many lives, but these methods often come with incredibly difficult side effects. Advancements in technology have brought new options to cancer care that hope to provide meaningful outcomes while minimizing the impact to the patient’s quality of life.

In this white paper Anshul Mangal, President of Project Farma (PF) & Precision ADVANCE, and Sumit Verma, Co-founder and Partner at Orchestra Life Sciences, discuss the power and potential of radioligand therapies and its impact on the treatment of a number of cancers.

(more…)

Load More Posts